THAILAND has approved an affordable generic version of the anti-impotence drug Viagra to go on sale RIGHT NOW  as the country looks to combat rampant counterfeit production

 The Thai diamond-shaped little blue pill, which resembles the original produced by US pharmaceutical giant Pfizer, is called “Sidegra” and is available on prescription across the country since October 1th .2012

 Thailand’s Food and Drug Administration (FDA) said it’s ten times cheaper than full-price Viagra, depends on the pharmacist and individual exporters.

 “This measure will solve widespread production of fake drugs by increasing accessibility to the legal version,” FDA secretary general said in a statement.

 The Government Pharmaceutical Organization (GPO) of Thailand is a state enterprise under Ministry of Public Health. It was founded in the year 1966 by merging of a pharmaceutical manufacturing plant(founded in 1939) and Pharmaceutical Department(founded in 1901) according to the GPO Act of 1966. The annual revenue of year 2009 is approx. 260 m USD. The total pharmaceutical product items are more than 300. The total staff is about 2,100.

 Vision: To be a leader in pharmaceutical products and medical supplies beneficial and essential to the Thai society and fairness.

 Mission: To manufacture .sell and supply quality pharmaceutical products and medical supplies with the aim to achieve world-class standard to develop business to ensure competitiveness and self-sustainability.

 To maintain price level of pharmaceutical products and medical supplies necessary for Thai society to ensure people’s accessibility.

 To research and develop new pharmaceutical products and medical supplies to serve the need of the country.

 To carry out business related pharmaceutical products and medical supplies manufacturing.

 The main responsibility of GPO is to produce medicines and pharmaceutical products to support the country’s public health. GPO was assigned to serve the national public health policy.

 Biological Product Department of GPO is, one of the Production Cluster, responsible for production of vaccines and antisera. At present, staff under this department is about 150. Our current products are JE(MB) vaccine, antiserum of tetanus and anti-snake venoms. The coming vaccines of dT, TT, DTP and DTP-HB are under reproduced. The under developed influenza vaccine was supported by WHO Grant and the Government including domestic and international networks. The H1N1 2009 PLAIV is now in phase II CT and will finish soon. The new strain under prepared for pandemic preparedness. The IIV for seasonal program will be scaled up in the industrial plant supported by Thai Government Budget.